The authors describe Medicare Advantage plans that screen for and provide supplemental benefits addressing social needs and ...

Serial KCCQ-TSS decline emerged as the most prominent pre-event signal for sudden death, contrasting with improving symptoms ...

The CRL comes after the FDA accepted the NDA for review in October 2025 and set a Prescription Drug User Fee Act target ...

James F. Howard, MD, discusses what he believes will be the next steps in treating myasthenia gravis. CAR-T therapies could ...

Real-world data suggest nirogacestat boosts response in desmoid tumor vs standard-of-care treatment, but small cohorts leave ...

Early detection of chronic kidney disease (CKD) means little if it does not lead to timely treatment, yet a significant gap ...

Many rural providers, like critical access hospitals, rely on cost-based reimbursement or flat, encounter-based payments like ...

The Medicare GLP-1 Bridge's July 1 launch is now the only concrete milestone on the calendar. Whether it becomes the ...

As obesity rates continue to climb in the US, clinicians across specialties are confronting the reality that although ...

Community oncology practices face major infrastructure and reimbursement gaps when delivering bispecific antibodies. Beyond ...

Clinicians gathered in Houston, Texas, to examine how newer drug options are reshaping cardiometabolic care and how ...

In part 2 of her interview with The American Journal of Managed Care®, Meng-Han Tsai, PhD, assistant professor at Augusta ...